RAC1 and inflammatory bowel disease: Furthermore, Bourgine et al. addressed that polymorphism of RAC1 gene can be regarded as a possible additional mechanism that might contribute to the inter-individual differences in the therapeutic effect of thiopurine drugs [32], which are widely applied for the treatment of inflammatory bowel diseases (IBD) [34].